Tom Collins is a freelance writer in South Florida who has written about medical topics from nasty infections to ethical dilemmas, runaway tumors to tornado-chasing doctors. He travels the globe gathering conference health news and lives in West Palm Beach.
News
Checklists, colleagues key when psychiatric patient overdoses
- Author:
- Thomas R. Collins
BONITA SPRINGS, FLA. – Psychiatrists grieve when a patient overdoses and dies, but talking to other clinicians and using specialized checklists...
News
Technical issues inhibit data collection on fentanyl
- Author:
- Thomas R. Collins
BONITA SPRINGS, FLA. – When it comes to mortality, the data on fentanyl are sometimes available, but they are cumbersome to collect, an expert...
News

Understanding properties of fentanyl, other opioids key to treatment
- Author:
- Thomas R. Collins
BONITA SPRINGS, FLA. – Fentanyl has opioid receptor affinity similar to that of morphine, research shows, and it’s not known why it is up to 100...
News

Drug test results ‘should not dictate treatment’
- Author:
- Thomas R. Collins
BONITA SPRINGS, FLA. – Many clinicians say they’re unsure about interpreting urine drug screens, but a 30-minute training session can make a big...
News

Rural teleprescribing for opioid use disorder shows success
- Author:
- Thomas R. Collins
BONITA SPRINGS, FLA. – More than 56% of rural counties in the country have no buprenorphine provider.
News

Psilocybin yields encouraging results in addiction studies
- Author:
- Thomas R. Collins
BONITA SPRINGS, FLA. – Small but tantalizing studies are showing benefits from treatment with psilocybin, the...
News

Paradigm shifts in palliative care
- Author:
- Thomas R. Collins
Hospitalists must be more keenly tuned in than ever to patients' precise needs.
News

Hospitalist NPs and PAs note progress
- Author:
- Thomas R. Collins
Integrating NPs and PAs into hospitalist groups successfully is a “nuanced and multilayered” process.
News
Researchers identify potential sickle cell disease target
- Author:
- Thomas R. Collins
The identification of heme-regulated inhibitor (HRI) was made using a tailored CRISPR screen of adult human erythroid cells.
News
Melanoma survival shorter in those given high dose glucocorticoids for ipilimumab-induced hypophysitis
- Author:
- Thomas R. Collins
Melanoma patients who take higher doses of glucocorticoids for hypophysitis induced by the checkpoint-inhibitor also had a shorter time to...
News

Benefits, drawbacks when hospitalists expand roles
- Author:
- Thomas R. Collins
Not all role expansion in hospital medicine is good role expansion, experts say.
News

Rethinking preop testing
- Author:
- Thomas R. Collins
ORLANDO – Think twice before ordering that preoperative test, experts say.
News

Eye-opening findings cast spondyloarthritis in new light, expert says
- Author:
- Thomas R. Collins
New findings show that, in a surprisingly high number of patients, inflammatory back pain does not lead to axial SpA
News

Caution crucial for stem cell transplant in scleroderma, despite potential interest
- Author:
- Thomas R. Collins
Long-term success of stem cell transplant in severe scleroderma patients might prompt patient interest, but most won’t be eligible, an expert says...
News

Newer IgG4 testing proving effective in assessing patients
- Author:
- Thomas R. Collins
Interpreting IgG4 levels when determining whether patients have IgG4-related disease can be a tricky matter, but newer tests are effective tools...